Golden State Wealth Management, LLC Crispr Therapeutics Ag Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 40 shares of CRSP stock, worth $1,681. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$1,681% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
57.8MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$333 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$315 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$126 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$125 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$117 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.28B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....